The charity publishes its gender and ethnicity pay gap reports.

3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland, including 2 breast cancer treatments and 1 for lung cancer.

A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE).

The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer.

Pixie Lott and other celebrity guests surprise children with messages of support in virtual Star Award ceremony, celebrates the courage of children with cancer.

Three new treatment options made available for cancer patients in Scotland.

During COP26, Cancer Research UK’s long-standing partner ScottishPower held an exclusive event, ‘Air Pollution and Cancer’, at their head office…

More than 600 people in England with a form of lung cancer could benefit from the innovative drug osimertinib (Tagrisso) after its approval by the National Institute for Health and Care Excellence.

Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England.

People who survive cancer in childhood have a higher risk of ill health as they grow older, according to new research published in The Lancet Regional Health – Europe.